These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 22423667

  • 1. High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma.
    Chen CY, Wu K, Lin WH, Lan TY, Wang SY, Sun JS, Weng PW, Yen RF, Yang RS.
    J Formos Med Assoc; 2012 Mar; 111(3):140-6. PubMed ID: 22423667
    [Abstract] [Full Text] [Related]

  • 2. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
    Yen RF, Chen CY, Cheng MF, Wu YW, Shiau YC, Wu K, Hong RL, Yu CJ, Wang KL, Yang RS.
    Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 4. Utility of Tc-99m GSA whole-body scintigraphy in detecting bone metastases from hepatocellular carcinoma.
    Sueyoshi K, Narabayashi I, Aratani T, Doi K, Komori T, Ogura Y, Utsunomiya K, Shimidzu T.
    Clin Nucl Med; 2001 Mar; 26(3):221-4. PubMed ID: 11245114
    [Abstract] [Full Text] [Related]

  • 5. Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE.
    Lee KH, Park JM, Yoon JK, Koh KC, Paik SW, Kim BT.
    Hepatogastroenterology; 2003 Mar; 50(54):1983-6. PubMed ID: 14696448
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D, Bhattacharya A, Mete UK, Mittal BR.
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [Abstract] [Full Text] [Related]

  • 7. Tc-99m PMT hepatobiliary scintigraphy in the differential diagnosis of extrahepatic metastases and hepatocellular carcinoma.
    Mochizuki T, Tsuda T, Sugawara Y, Tanaka H, Kikuchi T, Miyagawa M, Shimizu K, Murase K, Iuchi H, Onji M, Ikezoe J.
    Clin Nucl Med; 2000 Dec; 25(12):991-5. PubMed ID: 11129165
    [Abstract] [Full Text] [Related]

  • 8. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy].
    Suto Y, Tanigawa N, Iwamiya T, Kato T, Endo K, Shabana M, Ohta Y.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug 25; 53(8):953-9. PubMed ID: 8396760
    [Abstract] [Full Text] [Related]

  • 9. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
    Sahin E, Zincirkeser S, Akcan AB, Elboga U.
    J BUON; 2014 Aug 25; 19(1):291-6. PubMed ID: 24659678
    [Abstract] [Full Text] [Related]

  • 10. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP.
    Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Hell J Nucl Med; 2017 Aug 25; 20(3):237-240. PubMed ID: 29177262
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
    Zhang L, Chen L, Xie Q, Zhang Y, Cheng L, Li H, Wang J.
    BMC Med Imaging; 2015 Mar 01; 15():7. PubMed ID: 25885599
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer].
    Garcia JR, Moreno C, Valls E, Cozar P, Bassa P, Soler M, Alvarez-Moro FJ, Moragas M, Riera E.
    Rev Esp Med Nucl Imagen Mol; 2015 Mar 01; 34(3):155-61. PubMed ID: 25443648
    [Abstract] [Full Text] [Related]

  • 17. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS, Takeuchi R, Kasagi K, Misaki T, Miyamoto S, Iida Y, Hidaka A, Konishi J.
    Thyroid; 1997 Oct 01; 7(5):705-12. PubMed ID: 9349573
    [Abstract] [Full Text] [Related]

  • 18. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
    Kim MR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2008 Feb 01; 44(2):148-52. PubMed ID: 17350879
    [Abstract] [Full Text] [Related]

  • 19. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I.
    J Nucl Med; 2006 Feb 01; 47(2):287-97. PubMed ID: 16455635
    [Abstract] [Full Text] [Related]

  • 20. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S, Kirschbaum M, Fenzl G, Pickuth D.
    Rofo; 2009 Mar 01; 181(3):255-63. PubMed ID: 19229791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.